Jo Pharma Limited, a active public limited company, was established on 12 December 2015 in Delhi, Delhi, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U23109DL2015PLC288456. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹3.70 Cr.
Formerly known as Jindal Omran Pharma Private Limited, J.O. Pharma Private Limited. It upholds a compliant status. Its leadership includes Rakshit Jindal (Director), Ankit Jindal (Director), Suresh Baid (Director). Past directors included Shakun Jindal, Suresh Baid, Mustafa Aziz Rahi. It holds ₹13.76 Cr open charges and ₹9.56 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-7/3, Safdarjung Enclave, Opposite Deer Park, Delhi, Delhi, 110029.
U23109DL2015PLC288456
288456
12 December 2015
₹5.50 Cr
₹3.70 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Jo Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakshit Jindal | Director | 12 Dec 2015 | Current |
| Ankit Jindal | Director | 12 Dec 2015 | Current |
| Suresh Baid | Director | 22 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 28 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jo Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.38% increase. The company also saw a substantial improvement in profitability, with a 36.61% increase in profit. The company's net worth Soared by an impressive increase of 34.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Jo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹137,600,000.00
₹95,556,500.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2025 | Axis Bank Limited | ₹1.80 Cr | Open |
| 28 Sep 2023 | Others | ₹11.65 Cr | Open |
| 19 Nov 2019 | Axis Bank Limited | ₹3.10 M | Open |
| 19 Aug 2022 | Others | ₹5.00 Cr | Satisfied |
| 26 Apr 2022 | Axis Bank Limited | ₹4.56 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Jo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Jo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jo Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 26 Apr 2022 via Charge ID 100593834 with Axis Bank Limited was fully satisfied on 26 Mar 2025. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 1.80 Cr with Charge ID 101101664 was registered on 18 Mar 2025. was completed.
The activity Jo Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Suresh Baid was appointed as a Director was appointed as a Director on 22 Aug 2024 & has been associated with this company since 1 year 3 months . was documented.
Jo Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
A charge with Others amounted to Rs. 11.65 Cr with Charge ID 100788171 was registered on 28 Sep 2023. was recorded as a recent event.
The CIN of Jo Pharma Limited is U23109DL2015PLC288456.
Jo Pharma Limited is headquartered at B-7/3, Safdarjung Enclave, Opposite Deer Park, Delhi, Delhi, 110029.
Jo Pharma Limited was incorporated on 12 December 2015.
The current directors of Jo Pharma Limited are
The primary industry of Jo Pharma Limited is Manufacturing.
Jo Pharma Limited is unlisted.
The authorized capital of Jo Pharma Limited is ₹5.50 Cr, and the paid-up capital is ₹3.70 Cr.
The compliance status of Jo Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX